X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (15) 15
immunology (11) 11
index medicus (11) 11
p36 dna vaccine (10) 10
cutaneous leishmaniasis (9) 9
mice (9) 9
mice, inbred balb c (9) 9
antigens, protozoan - immunology (8) 8
balb/c mice (8) 8
visceral leishmaniasis (8) 8
leishmaniasis (7) 7
protozoan proteins - immunology (7) 7
vaccination (7) 7
immunization (6) 6
leishmania (6) 6
microbiology (6) 6
protozoan proteins - genetics (6) 6
vaccine (6) 6
vaccines, dna - immunology (6) 6
antigen (5) 5
antigens, protozoan - genetics (5) 5
female (5) 5
humans (5) 5
infantum p36/lack (5) 5
interferon-gamma (5) 5
leishmania infantum - immunology (5) 5
leishmaniasis vaccines - administration & dosage (5) 5
leishmaniasis, cutaneous - prevention & control (5) 5
leishmaniasis, visceral - immunology (5) 5
protozoan vaccines - immunology (5) 5
vaccines (5) 5
cd4 t-cells (4) 4
confers protective immunity (4) 4
immunization, secondary (4) 4
infection (4) 4
infectious diseases (4) 4
leishmaniasis vaccines - immunology (4) 4
leishmaniasis, cutaneous - immunology (4) 4
leishmaniasis, visceral - prevention & control (4) 4
major infection (4) 4
parasitology (4) 4
prime-boost vaccination (4) 4
administration, intranasal (3) 3
antibodies, protozoan - blood (3) 3
disease models, animal (3) 3
dna vaccines (3) 3
immune-response (3) 3
in-vivo (3) 3
interferon-gamma - metabolism (3) 3
lack (3) 3
leishmania - immunology (3) 3
leishmaniasis - prevention & control (3) 3
liver - parasitology (3) 3
medical research (3) 3
protein (3) 3
protozoan vaccines - administration & dosage (3) 3
recombinant (3) 3
spleen - parasitology (3) 3
susceptible balb/c mice (3) 3
t-cells (3) 3
t-lymphocytes - immunology (3) 3
vaccinia virus - genetics (3) 3
adjuvant (2) 2
adjuvants, immunologic - administration & dosage (2) 2
amazonensis (2) 2
antigenicity (2) 2
antigens (2) 2
biology (2) 2
canine visceral leishmaniasis (2) 2
cd4-positive t-lymphocytes - immunology (2) 2
cd4-positive t-lymphocytes - metabolism (2) 2
cd8 (2) 2
cd8 t-cells (2) 2
cysteine proteinases (2) 2
cytokines (2) 2
dendritic cells (2) 2
dna (2) 2
dogs (2) 2
experimental visceral leishmaniasis (2) 2
genetic aspects (2) 2
ifn-gamma production (2) 2
immune response (2) 2
immune-responses (2) 2
immunity (2) 2
immunity, cellular - immunology (2) 2
intranasal vaccination (2) 2
leishmania infantum chagasi (2) 2
leishmania major - immunology (2) 2
leishmaniasis vaccines - genetics (2) 2
leishmaniasis, cutaneous - parasitology (2) 2
leishmaniasis, visceral - parasitology (2) 2
lymphocyte activation - immunology (2) 2
lymphocytes (2) 2
lymphocytes - immunology (2) 2
lymphocytes t (2) 2
medicine, research & experimental (2) 2
murine leishmaniasis (2) 2
nitric oxide - metabolism (2) 2
p36/lack antigen (2) 2
parasitic diseases (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical and Vaccine Immunology, ISSN 1556-6811, 07/2017, Volume 24, Issue 7
From experimental models and the analyses of patients, it is well documented that antigen-specific T cells are critical for protection against Leishmania... 
Adjuvants | Vaccine | Vector | Leishmania | Protein | INFECTIOUS DISEASES | SURFACE PROTEIN GP63 | MICROBIOLOGY | P36/LACK ANTIGEN | IMMUNOLOGY | NUCLEOSIDE HYDROLASE | SUSCEPTIBLE BALB/C MICE | P36(LACK) DNA VACCINE | CUTANEOUS LEISHMANIASIS | vaccine | PROTECTIVE IMMUNITY | MAJOR INFECTION | protein | CENTRIN DELETED PARASITES | vector | VISCERAL LEISHMANIASIS | adjuvants
Journal Article
Plasmid, ISSN 0147-619X, 01/2019, Volume 101, pp. 35 - 42
DNA vaccines require a vector to replicate genes and express encoding antigens. Antibiotic resistance genes are often used as selection markers, which must not... 
Plasmid | Enoyl-ACP reductase | Th1 response | Triclosan | LACK/p36 | Leishmaniasis | Third generation vaccine | Selection marker | CpG islands | PROTECTION | INCREASES | MICROBIOLOGY | IMMUNIZATION | DNA VACCINES | IMMUNE-RESPONSES | IN-VIVO | GENETICS & HEREDITY | INFANTUM | VISCERAL LEISHMANIASIS | Vaccines, DNA - genetics | Antigens, Protozoan - immunology | Leishmaniasis Vaccines - immunology | Leishmaniasis, Visceral - prevention & control | Fatty Acid Synthase, Type II - genetics | Humans | Vaccines, DNA - immunology | Leishmaniasis, Visceral - immunology | Triclosan - pharmacology | Protozoan Proteins - genetics | Th1 Cells - immunology | Vaccines, DNA - administration & dosage | HEK293 Cells | Antigens, Protozoan - genetics | Leishmaniasis, Visceral - parasitology | Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) - genetics | Cytomegalovirus - genetics | Promoter Regions, Genetic | Th1 Cells - drug effects | Plasmids - immunology | Leishmaniasis Vaccines - administration & dosage | Genetic Markers | Plasmids - metabolism | Drug Resistance, Microbial | Animals | Enhancer Elements, Genetic | Escherichia coli - genetics | Dogs | Leishmania infantum - drug effects | CpG Islands | Escherichia coli Proteins - genetics | Leishmania infantum - immunology | Th1 Cells - parasitology | Leishmaniasis Vaccines - genetics | Plasmids - administration & dosage | Protozoan Proteins - immunology
Journal Article
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33161
Journal Article
Microbes and Infection, ISSN 1286-4579, 2006, Volume 8, Issue 3, pp. 810 - 822
Journal Article
European Journal of Immunology, ISSN 0014-2980, 03/2008, Volume 38, Issue 3, pp. 706 - 719
Heterologous prime‐boost vaccination employing DNA‐vaccinia virus (VACV) modality using the Leishmania homologue of receptors for activated C kinase (LACK)... 
Adjuvant | Vaccine | NKT cells | Leishmania | Memory | memory | PLASMACYTOID-DENDRITIC-CELLS | IMMUNOLOGICAL MEMORY | AMAZONENSIS INFECTION | IMMUNOLOGY | INFANTUM P36/LACK | CUTANEOUS LEISHMANIASIS | vaccine | adjuvant | IMMUNE-RESPONSES | EXPERIMENTAL VISCERAL LEISHMANIASIS | IN-VIVO | LIGAND ALPHA-GALACTOSYLCERAMIDE | IMMUNIZATION REGIMENS | Leishmaniasis - prevention & control | Antigens, Protozoan - immunology | Granzymes - metabolism | Vaccines, DNA - immunology | Interferon-gamma - metabolism | Lymphocyte Depletion | Protozoan Proteins - genetics | Leishmaniasis - pathology | Vaccinia virus - genetics | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Vaccination - methods | T-Lymphocytes - metabolism | Mice, Mutant Strains | CD8-Positive T-Lymphocytes - metabolism | Interleukin-10 - metabolism | Killer Cells, Natural - immunology | Antigens, Protozoan - genetics | Skin - pathology | Skin - immunology | Leishmaniasis - immunology | Antibody Formation - immunology | CD4-Positive T-Lymphocytes - metabolism | Skin - parasitology | Vaccines, DNA - therapeutic use | Genetic Vectors - genetics | Immunity, Cellular - immunology | Animals | Galactosylceramides - immunology | T-Lymphocytes - immunology | Mice | Mice, Inbred BALB C | Killer Cells, Natural - metabolism | CD8-Positive T-Lymphocytes - immunology | Nitric Oxide - metabolism | Protozoan Proteins - immunology
Journal Article